Walking Ventures
VC Fund
London, United Kingdom
Walking Ventures is a seed fund which invests in early-stage Internet and other technology startups based in Europe. The fund is a private vehicle controlled by Tim Jackson, a leading figure in the European technology scene as a venture capitalist, entrepreneur, angel investor, commentator and technology journalist.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Walking Ventures invests in
Stages Walking Ventures invests in
Countries Walking Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $170k–$2.2M
- Angel
- $273k–$917k
- Series A
- $1.2M–$13M
Investment Focus
Industry
- Software 6 (22%)
- Health Care 5 (19%)
- Internet 4 (15%)
- Artificial Intelligence 4 (15%)
- Analytics 3 (11%)
Stage
- Seed 16 (59%)
- Series A 5 (19%)
- Angel 3 (11%)
- Funding Round 2 (7%)
- Convertible Note 1 (4%)
Country
- United Kingdom 18 (67%)
- United States 5 (19%)
- Sweden 3 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Tim Jackson
Founder, CEO, General Partner & Partner
|
Founder, CEO, General Partner & Partner | Total investments: 18 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Tessian’s mission is to secure the human layer. Using machine learning technology, Tessian automatically stops data breaches and security threats caused by human error - like data exfiltration, accidental data loss, business email compromise, and phishing attacks - with minimal disruption to employees' workflow. As a result, employees areempowered to do their best work, without security getting in their way. Founded in 2013, Tessian is backed by renowned investors like Sequoia, Accel, March Capital, and Balderton, and has offices in San Francisco and London. | $13M / Series A / Jun 17, 2018 | |
|
|
Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform.They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allowspatients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.Oviva was founded in 2013 and is based in Altendorf (Switzerland) with offices in Zurich (Switzerland), London (United Kingdom), and Berlin (Germany). | $12M / Series A / Nov 20, 2017 | |
|
|
Smart technology to deliver a better guest experience, increase secondary spend and understand visitor behaviour like never before. | Seed / Mar 09, 2017 | |
|
|
Attraction Technology manufacture a range of technologies for visitor attractions around the world, and we hand build everything in the UK. | Seed / Mar 01, 2017 | |
|
|
Cipher Surgical Limited is a medical device company established to design, patent and globally market a unique laparoscopic medical device for maintaining a clear distal window of the laparoscope during an operative procedure. | $1.3M / Feb 01, 2017 | |
|
|
Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music.Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness,that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication.Founded in 2010, Audio Analytic is based in Cambridge, UK. | $5.5M / Series A / Jan 03, 2017 | |
|
|
Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain. Our treatments are clinically proven and give patients access to a personal, licensed physical therapist, an individualized exercise plan, interactive education about the condition, and progress tracking — all through auser-friendly app. Peer-reviewed studies show that Joint Academy patients reduce their pain, change their minds about surgery, and quit painkillers. Joint Academy is now available to patients in Sweden, the US, the UK, France, and Germany. | $2.2M / Seed / Dec 06, 2016 | |
|
|
At Kheiron, we are going where only a few have gone before; seeking a new understanding of cancer and how to detect it using artificial intelligence and human insight.We’ve made significant breakthroughs with our breast cancer screening product Mia but this is just the beginning of our journey. Ultimately we want to radically improve the outcomesfor cancer patients by pioneering a new era of, what we call, precision radiology.While this all sounds very serious and it is, we believe in having fun along the way. Karaoke is our favourite sport. We also have an incredible crew from more than twenty different countries and offices in London, Budapest, Amsterdam and San Francisco. Giving every woman a better fighting chance against cancer. | $13K / Seed / Sep 08, 2016 | |
|
|
Contellio analyses and takes marketers' existing content and converts it into visuals like presentations, animations, and infographics. | $170K / Convertible Note / Jun 16, 2016 | |
|
|
Goodlord offers the cloud-based software to help estate agents, landlords, and tenants manage the rental process.Its cloud-based software digitizes tenancy creation and progression, allowing Goodlord to cut pointless, time-consuming administration for agents while transforming the tenant and landlord experience. Goodlord also provides ashop-front for agents to easily offer services that provide more value to their tenants and landlords, such as insurance and utility services.Philip Mundy, Richard White, and Tom Mundy founded the company in 2014. It was established in London, England. | $2.6M / Seed / May 18, 2016 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Walking Ventures invest in?
Walking Ventures invests primarily in Software, Health Care and Internet startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Walking Ventures's check size?
Walking Ventures typically joins rounds of $170k–$2.2M at Seed, $273k–$917k at Angel and $1.2M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Walking Ventures participates in.
How do I contact Walking Ventures?
Public channels for Walking Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Walking Ventures?
The team at Walking Ventures includes Tim Jackson (Founder, CEO, General Partner & Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!